LLY logo

Eli Lilly and Company (LLY) Net income

annual net income:

$10.59B+$5.35B(+102.08%)
December 31, 2024

Summary

  • As of today (April 12, 2025), LLY annual net profit is $10.59 billion, with the most recent change of +$5.35 billion (+102.08%) on December 31, 2024.
  • During the last 3 years, LLY annual net income has risen by +$5.01 billion (+89.73%).
  • LLY annual net income is now at all-time high.

Performance

LLY Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYincome statement metrics

quarterly net income:

$4.41B+$3.44B(+354.48%)
December 31, 2024

Summary

  • As of today (April 12, 2025), LLY quarterly net profit is $4.41 billion, with the most recent change of +$3.44 billion (+354.48%) on December 31, 2024.
  • Over the past year, LLY quarterly net income has stayed the same.
  • LLY quarterly net income is now at all-time high.

Performance

LLY quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYincome statement metrics

TTM net income:

$10.59B+$2.22B(+26.52%)
December 31, 2024

Summary

  • As of today (April 12, 2025), LLY TTM net profit is $10.59 billion, with the most recent change of +$2.22 billion (+26.52%) on December 31, 2024.
  • Over the past year, LLY TTM net income has stayed the same.
  • LLY TTM net income is now at all-time high.

Performance

LLY TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

LLY Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+102.1%0.0%0.0%
3 y3 years+89.7%+227.9%+86.2%
5 y5 years+27.3%+227.9%+86.2%

LLY Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+102.1%at high+7782.6%at high+112.3%
5 y5-yearat high+102.1%at high+7782.6%at high+112.3%
alltimeall timeat high+611.1%at high+221.5%at high+611.1%

Eli Lilly and Company Net income History

DateAnnualQuarterlyTTM
Dec 2024
$10.59B(+102.1%)
$4.41B(+354.5%)
$10.59B(+26.5%)
Sep 2024
-
$970.30M(-67.3%)
$8.37B(+14.0%)
Jun 2024
-
$2.97B(+32.3%)
$7.34B(+19.6%)
Mar 2024
-
$2.24B(+2.4%)
$6.14B(+17.1%)
Dec 2023
$5.24B(-16.1%)
$2.19B(-3914.8%)
$5.24B(+5.1%)
Sep 2023
-
-$57.40M(-103.3%)
$4.99B(-23.2%)
Jun 2023
-
$1.76B(+31.1%)
$6.50B(+14.3%)
Mar 2023
-
$1.34B(-30.6%)
$5.69B(-8.9%)
Dec 2022
$6.24B(+11.9%)
$1.94B(+33.5%)
$6.24B(+3.5%)
Sep 2022
-
$1.45B(+52.4%)
$6.03B(+6.0%)
Jun 2022
-
$952.50M(-49.9%)
$5.69B(-7.1%)
Mar 2022
-
$1.90B(+10.2%)
$6.13B(+9.8%)
Dec 2021
$5.58B(-9.9%)
$1.73B(+55.5%)
$5.58B(-6.5%)
Sep 2021
-
$1.11B(-20.1%)
$5.97B(-1.6%)
Jun 2021
-
$1.39B(+2.6%)
$6.07B(-0.4%)
Mar 2021
-
$1.36B(-36.0%)
$6.09B(-1.6%)
Dec 2020
$6.19B(-25.5%)
$2.12B(+75.2%)
$6.19B(+11.1%)
Sep 2020
-
$1.21B(-14.4%)
$5.57B(-0.8%)
Jun 2020
-
$1.41B(-3.1%)
$5.62B(+1.5%)
Mar 2020
-
$1.46B(-2.6%)
$5.53B(-33.5%)
Dec 2019
$8.32B(+157.4%)
$1.50B(+19.3%)
$8.32B(+4.7%)
Sep 2019
-
$1.25B(-5.5%)
$7.95B(+1.3%)
Jun 2019
-
$1.33B(-68.7%)
$7.84B(+25.4%)
Mar 2019
-
$4.24B(+277.0%)
$6.26B(+93.6%)
Dec 2018
$3.23B(-1683.5%)
$1.13B(-2.1%)
$3.23B(+618.1%)
Sep 2018
-
$1.15B(-542.3%)
$450.10M(-413.0%)
Jun 2018
-
-$259.90M(-121.3%)
-$143.80M(-112.8%)
Mar 2018
-
$1.22B(-173.5%)
$1.12B(-650.8%)
Dec 2017
-$204.10M(-107.5%)
-$1.66B(-398.2%)
-$204.10M(-109.2%)
Sep 2017
-
$555.60M(-44.9%)
$2.22B(-9.1%)
Jun 2017
-
$1.01B(-1009.7%)
$2.45B(+11.9%)
Mar 2017
-
-$110.80M(-114.4%)
$2.19B(-20.1%)
Dec 2016
$2.74B(+13.7%)
$771.80M(-0.8%)
$2.74B(+12.0%)
Sep 2016
-
$778.00M(+4.1%)
$2.44B(-0.9%)
Jun 2016
-
$747.70M(+69.9%)
$2.47B(+6.3%)
Mar 2016
-
$440.10M(-8.0%)
$2.32B(-3.7%)
Dec 2015
$2.41B(+0.7%)
$478.40M(-40.2%)
$2.41B(+2.1%)
Sep 2015
-
$799.70M(+33.1%)
$2.36B(+14.5%)
Jun 2015
-
$600.80M(+13.5%)
$2.06B(-6.1%)
Mar 2015
-
$529.50M(+23.6%)
$2.19B(-8.3%)
Dec 2014
$2.39B(-49.0%)
$428.50M(-14.4%)
$2.39B(-11.1%)
Sep 2014
-
$500.60M(-31.8%)
$2.69B(-20.7%)
Jun 2014
-
$733.50M(+0.8%)
$3.39B(-12.2%)
Mar 2014
-
$727.90M(+0.1%)
$3.86B(-17.5%)
Dec 2013
$4.68B(+14.6%)
$727.50M(-39.5%)
$4.68B(-2.1%)
Sep 2013
-
$1.20B(-0.3%)
$4.78B(-2.5%)
Jun 2013
-
$1.21B(-22.1%)
$4.91B(+6.1%)
Mar 2013
-
$1.55B(+87.1%)
$4.63B(+13.1%)
Dec 2012
$4.09B(-6.0%)
$827.30M(-37.6%)
$4.09B(-0.8%)
Sep 2012
-
$1.33B(+43.6%)
$4.12B(+2.2%)
Jun 2012
-
$923.60M(-8.7%)
$4.03B(-6.4%)
Mar 2012
-
$1.01B(+17.8%)
$4.30B(-1.0%)
Dec 2011
$4.35B(-14.2%)
$858.20M(-30.6%)
$4.35B(-6.7%)
Sep 2011
-
$1.24B(+3.3%)
$4.66B(-1.4%)
Jun 2011
-
$1.20B(+13.4%)
$4.73B(-3.1%)
Mar 2011
-
$1.06B(-9.7%)
$4.88B(-3.8%)
Dec 2010
$5.07B(+17.1%)
$1.17B(-10.2%)
$5.07B(+5.3%)
Sep 2010
-
$1.30B(-3.4%)
$4.82B(+8.1%)
Jun 2010
-
$1.35B(+8.1%)
$4.45B(+4.5%)
Mar 2010
-
$1.25B(+36.3%)
$4.26B(-1.5%)
Dec 2009
$4.33B(-308.9%)
$915.40M(-2.8%)
$4.33B(-2104.1%)
Sep 2009
-
$941.80M(-18.7%)
-$216.00M(-86.7%)
Jun 2009
-
$1.16B(-11.8%)
-$1.62B(-11.0%)
Mar 2009
-
$1.31B(-136.2%)
-$1.82B(-12.0%)
Dec 2008
-$2.07B(-170.2%)
-$3.63B(+679.5%)
-$2.07B(-185.9%)
Sep 2008
-
-$465.60M(-148.6%)
$2.41B(-36.6%)
Jun 2008
-
$958.80M(-9.9%)
$3.80B(+8.4%)
Mar 2008
-
$1.06B(+24.6%)
$3.51B(+18.8%)
Dec 2007
$2.95B(+10.9%)
$854.40M(-7.8%)
$2.95B(+32.4%)
Sep 2007
-
$926.30M(+39.6%)
$2.23B(+2.4%)
Jun 2007
-
$663.60M(+30.5%)
$2.18B(-6.8%)
Mar 2007
-
$508.70M(+284.5%)
$2.34B(-12.2%)
Dec 2006
$2.66B(+34.5%)
$132.30M(-84.9%)
$2.66B(-17.6%)
Sep 2006
-
$873.60M(+6.3%)
$3.23B(+2.5%)
Jun 2006
-
$822.00M(-1.5%)
$3.15B(+51.7%)
Mar 2006
-
$834.80M(+19.2%)
$2.08B(+5.0%)
Dec 2005
$1.98B(+9.4%)
$700.60M(-11.8%)
$1.98B(+55.1%)
Sep 2005
-
$794.40M(-415.2%)
$1.28B(+3.2%)
Jun 2005
-
-$252.00M(-134.2%)
$1.24B(-42.3%)
Mar 2005
-
$736.60M(<-9900.0%)
$2.15B(+18.6%)
Dec 2004
$1.81B
-$2.40M(-100.3%)
$1.81B(-29.3%)
Sep 2004
-
$755.20M(+15.0%)
$2.56B(+1.6%)
DateAnnualQuarterlyTTM
Jun 2004
-
$656.90M(+64.1%)
$2.52B(-1.4%)
Mar 2004
-
$400.40M(-46.4%)
$2.55B(-0.3%)
Dec 2003
$2.56B(-5.4%)
$747.20M(+4.6%)
$2.56B(+0.4%)
Sep 2003
-
$714.40M(+3.2%)
$2.55B(+1.2%)
Jun 2003
-
$692.20M(+70.1%)
$2.52B(+1.4%)
Mar 2003
-
$407.00M(-44.7%)
$2.49B(-8.2%)
Dec 2002
$2.71B(-2.6%)
$736.30M(+7.7%)
$2.71B(+6.3%)
Sep 2002
-
$683.90M(+3.9%)
$2.55B(+4.7%)
Jun 2002
-
$658.50M(+4.7%)
$2.43B(-6.5%)
Mar 2002
-
$629.20M(+9.4%)
$2.60B(-6.4%)
Dec 2001
$2.78B(-9.1%)
$575.40M(+0.9%)
$2.78B(-6.5%)
Sep 2001
-
$570.10M(-31.1%)
$2.97B(-6.6%)
Jun 2001
-
$827.70M(+2.6%)
$3.18B(+5.3%)
Mar 2001
-
$806.80M(+5.1%)
$3.02B(-1.3%)
Dec 2000
$3.06B(+12.4%)
$767.30M(-1.5%)
$3.06B(-0.6%)
Sep 2000
-
$778.80M(+16.9%)
$3.08B(+1.5%)
Jun 2000
-
$666.20M(-21.2%)
$3.03B(+3.1%)
Mar 2000
-
$845.50M(+7.5%)
$2.94B(+8.1%)
Dec 1999
$2.72B(+29.7%)
$786.30M(+7.3%)
$2.72B(+8.8%)
Sep 1999
-
$732.60M(+27.1%)
$2.50B(+9.4%)
Jun 1999
-
$576.40M(-7.9%)
$2.29B(+3.9%)
Mar 1999
-
$625.70M(+10.3%)
$2.20B(+5.0%)
Dec 1998
$2.10B(-644.8%)
$567.30M(+9.5%)
$2.10B(+5.5%)
Sep 1998
-
$518.20M(+5.5%)
$1.99B(+3.2%)
Jun 1998
-
$491.30M(-5.7%)
$1.93B(-749.6%)
Mar 1998
-
$521.10M(+13.9%)
-$296.60M(-23.0%)
Dec 1997
-$385.10M(-125.3%)
$457.50M(+0.1%)
-$385.10M(-18.0%)
Sep 1997
-
$456.90M(-126.4%)
-$469.60M(-8.1%)
Jun 1997
-
-$1.73B(-500.4%)
-$510.90M(-132.6%)
Mar 1997
-
$432.60M(+16.0%)
$1.57B(+2.8%)
Dec 1996
$1.52B(-33.5%)
$373.00M(-10.3%)
$1.52B(+2.0%)
Sep 1996
-
$415.60M(+20.2%)
$1.49B(-35.2%)
Jun 1996
-
$345.70M(-11.2%)
$2.31B(+0.8%)
Mar 1996
-
$389.20M(+13.6%)
$2.29B(-0.2%)
Dec 1995
$2.29B(+78.1%)
$342.60M(-72.1%)
$2.29B(+2.3%)
Sep 1995
-
$1.23B(+275.4%)
$2.24B(+68.4%)
Jun 1995
-
$327.10M(-16.8%)
$1.33B(-1.4%)
Mar 1995
-
$393.20M(+35.5%)
$1.35B(+4.9%)
Dec 1994
$1.29B(+167.8%)
$290.10M(-9.0%)
$1.29B(+172.2%)
Sep 1994
-
$318.70M(-8.0%)
$472.40M(+5.4%)
Jun 1994
-
$346.60M(+4.8%)
$448.10M(-0.0%)
Mar 1994
-
$330.70M(-163.2%)
$448.30M(-6.6%)
Dec 1993
$480.20M(-32.2%)
-$523.60M(-277.9%)
$480.20M(-63.5%)
Sep 1993
-
$294.40M(-15.1%)
$1.31B(+74.8%)
Jun 1993
-
$346.80M(-4.4%)
$752.10M(+1.2%)
Mar 1993
-
$362.60M(+16.5%)
$743.50M(-9.7%)
Dec 1992
$708.70M(-46.1%)
$311.20M(-215.9%)
$823.50M(+0.0%)
Sep 1992
-
-$268.50M(-179.4%)
$823.40M(-40.7%)
Jun 1992
-
$338.20M(-23.6%)
$1.39B(+1.5%)
Mar 1992
-
$442.60M(+42.3%)
$1.37B(+4.1%)
Dec 1991
$1.31B(+16.6%)
$311.10M(+4.6%)
$1.31B(+4.4%)
Sep 1991
-
$297.50M(-6.3%)
$1.26B(+3.3%)
Jun 1991
-
$317.50M(-18.3%)
$1.22B(+3.7%)
Mar 1991
-
$388.60M(+52.2%)
$1.18B(+4.2%)
Dec 1990
$1.13B(+20.0%)
$255.30M(-0.6%)
$1.13B(+2.7%)
Sep 1990
-
$256.80M(-6.4%)
$1.10B(+4.2%)
Jun 1990
-
$274.40M(-19.5%)
$1.05B(+5.8%)
Mar 1990
-
$340.80M(+51.3%)
$995.60M(+6.0%)
Dec 1989
$939.50M(+23.5%)
$225.30M(+6.1%)
$939.50M(+5.6%)
Sep 1989
-
$212.40M(-2.2%)
$889.90M(+4.8%)
Jun 1989
-
$217.10M(-23.7%)
$848.90M(+4.5%)
Mar 1989
-
$284.70M(+62.0%)
$812.50M(+6.8%)
Dec 1988
$761.00M(+18.2%)
$175.70M(+2.5%)
$761.00M(+55.2%)
Sep 1988
-
$171.40M(-5.1%)
$490.30M(+4.6%)
Jun 1988
-
$180.70M(-22.5%)
$468.90M(+6.9%)
Mar 1988
-
$233.20M(-345.5%)
$438.50M(+6.8%)
Dec 1987
$643.70M(+15.3%)
-$95.00M(-163.3%)
$410.50M(-34.8%)
Sep 1987
-
$150.00M(-0.2%)
$629.80M(+2.3%)
Jun 1987
-
$150.30M(-26.8%)
$615.40M(+4.2%)
Mar 1987
-
$205.20M(+65.1%)
$590.80M(+5.8%)
Dec 1986
$558.20M(+7.8%)
$124.30M(-8.3%)
$558.20M(-0.0%)
Sep 1986
-
$135.60M(+7.9%)
$558.40M(+2.5%)
Jun 1986
-
$125.70M(-27.2%)
$544.90M(+2.9%)
Mar 1986
-
$172.60M(+38.6%)
$529.30M(+2.3%)
Dec 1985
$517.60M(+5.6%)
$124.50M(+2.0%)
$517.60M(+1.3%)
Sep 1985
-
$122.10M(+10.9%)
$510.90M(+2.1%)
Jun 1985
-
$110.10M(-31.6%)
$500.50M(-0.8%)
Mar 1985
-
$160.90M(+36.6%)
$504.40M(+2.9%)
Dec 1984
$490.20M
$117.80M(+5.5%)
$490.20M(+31.6%)
Sep 1984
-
$111.70M(-2.0%)
$372.40M(+42.8%)
Jun 1984
-
$114.00M(-22.3%)
$260.70M(+77.7%)
Mar 1984
-
$146.70M
$146.70M

FAQ

  • What is Eli Lilly and Company annual net profit?
  • What is the all time high annual net income for Eli Lilly and Company?
  • What is Eli Lilly and Company annual net income year-on-year change?
  • What is Eli Lilly and Company quarterly net profit?
  • What is the all time high quarterly net income for Eli Lilly and Company?
  • What is Eli Lilly and Company quarterly net income year-on-year change?
  • What is Eli Lilly and Company TTM net profit?
  • What is the all time high TTM net income for Eli Lilly and Company?
  • What is Eli Lilly and Company TTM net income year-on-year change?

What is Eli Lilly and Company annual net profit?

The current annual net income of LLY is $10.59B

What is the all time high annual net income for Eli Lilly and Company?

Eli Lilly and Company all-time high annual net profit is $10.59B

What is Eli Lilly and Company annual net income year-on-year change?

Over the past year, LLY annual net profit has changed by +$5.35B (+102.08%)

What is Eli Lilly and Company quarterly net profit?

The current quarterly net income of LLY is $4.41B

What is the all time high quarterly net income for Eli Lilly and Company?

Eli Lilly and Company all-time high quarterly net profit is $4.41B

What is Eli Lilly and Company quarterly net income year-on-year change?

Over the past year, LLY quarterly net profit has changed by $0.00 (0.00%)

What is Eli Lilly and Company TTM net profit?

The current TTM net income of LLY is $10.59B

What is the all time high TTM net income for Eli Lilly and Company?

Eli Lilly and Company all-time high TTM net profit is $10.59B

What is Eli Lilly and Company TTM net income year-on-year change?

Over the past year, LLY TTM net profit has changed by $0.00 (0.00%)
On this page